Alison Bretnall
About Alison Bretnall
Alison Bretnall is a Director at Bristol Myers Squibb in Moreton, England, with 29 years of experience as an Analytical Chemist in the pharmaceutical industry.
Current Roles at Bristol Myers Squibb
Alison Bretnall currently holds multiple roles at Bristol Myers Squibb. She is a Director based in Moreton, England, United Kingdom, and serves as the Associate Director of Analytical & Bioanalytical Operations in Moreton, Wirral, UK. Bretnall also leads as the Group Leader in ABD.
Previous Positions and Experience
Alison Bretnall has extensive experience within the pharmaceutical industry. Prior to her current roles, she worked as a Group Leader at Bristol Myers Squibb from 1992 to 2012. Before joining Bristol Myers Squibb, she spent two years as an Analytical Scientist at Ciba Geigy Pharmaceuticals. Her career in analytical chemistry spans 29 years.
Educational Background
Alison Bretnall studied Chemistry at The Manchester Metropolitan University, where she achieved Graduateship of the Royal Society of Chemistry from 1981 to 1984. Her educational background has been foundational to her career in analytical chemistry.
Expertise in Analytical Techniques
Over her career, Alison Bretnall has gained expertise in a wide range of analytical techniques. These include High-Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ultraviolet (UV) spectroscopy, Dissolution testing, and Titration Power (TPW) analysis. Her skills are applied in the development of pharmaceutical compounds from Phase I through to regulatory filing.
Leadership and Contributions
Alison Bretnall leads the Global Validation Best Practices Team at Bristol Myers Squibb. She has contributed to the pharmaceutical field by co-authoring a chapter in the Handbook of Pharmaceutical Analysis. Additionally, she has played a significant role in regulatory compliance, being audit-facing for MHRA audits with only minor observations granted for the site.